1,188 filings
Page 4 of 60
8-K
w46rjht
2 Mar 20
VIVUS Completes Enrollment in Phase 4 Safety and Efficacy Study of
7:43am
4
td36ln w79u
24 Feb 20
VIVUS / HERM ROSENMAN ownership change
6:07pm
4
e0dz3k0 kn4e
24 Feb 20
VIVUS / Jorge MD Plutzky ownership change
6:06pm
4
afas4ros1wvo1tgc
24 Feb 20
VIVUS / David Y Norton ownership change
6:06pm
4
9w9j5apa 2y
24 Feb 20
VIVUS / THOMAS BRAXTON KING ownership change
6:06pm
4
i29w7w
24 Feb 20
VIVUS / EDWARD A KANGAS ownership change
6:05pm
4
pey6ft9sked 9epvcl
24 Feb 20
VIVUS / Karen E. Ferrell ownership change
6:05pm
8-K
zghtxp7ytj68
21 Feb 20
Departure of Directors or Certain Officers
4:05pm
8-K
s4cmhuga
19 Feb 20
VIVUS Announces Commercial Launch of Qsymia®in the Republic of Korea Establishing New Royalty Revenue Stream
7:35am
SC 13G/A
jjg451c84
13 Feb 20
Vivus Inc
12:00am
8-K
ug6fpwfxh9maz2 d48g8
5 Feb 20
VIVUS Receives U.S. Food and Drug Administration Approval for Improved Formulation of PANCREAZE® with a 36-Month Shelf Life
7:35am
SC 13G
ug4x2hymr4v
4 Feb 20
Beneficial ownership report
4:03pm
4
sro81 j7gb9v0
31 Jan 20
VIVUS / John P. Amos ownership change
5:25pm
4
d66sgdpvm5ddekrgcw4c
31 Jan 20
VIVUS / Mark K Oki ownership change
5:25pm
4
6mmudlgu38d5zqjuzujc
31 Jan 20
VIVUS / John L Slebir ownership change
5:24pm
4
w0gprt2jm
31 Jan 20
VIVUS / Santosh T Varghese ownership change
5:23pm
8-K
9d01c
31 Jan 20
Departure of Directors or Certain Officers
4:35pm
8-K
4axjm
7 Jan 20
Other Events
7:35am
8-A12B
xqp6ru
31 Dec 19
Registration of securities on exchange
7:50am